Kirchner T - Search Results

1

Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.

Michl M, Thurmaier J, Schubert-Fritschle G, Wiedemann M, Laubender RP, Nüssler NC, Ruppert R, Kleeff J, Schepp W, Reuter C, Löhe F, Karthaus M, Neumann J, Kirchner T, Engel J, Heinemann V. Michl M, et al. Among authors: kirchner t. Clin Colorectal Cancer. 2015 Dec;14(4):281-90. doi: 10.1016/j.clcc.2015.05.009. Epub 2015 Jun 6. Clin Colorectal Cancer. 2015. PMID: 26123495

2

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, Jung A, Kirchner T, Brabletz T. Spaderna S, et al. Among authors: kirchner t. Gastroenterology. 2006 Sep;131(3):830-40. doi: 10.1053/j.gastro.2006.06.016. Gastroenterology. 2006. PMID: 16952552

3

CD133 expression is an independent prognostic marker for low survival in colorectal cancer.

Horst D, Kriegl L, Engel J, Kirchner T, Jung A. Horst D, et al. Among authors: kirchner t. Br J Cancer. 2008 Oct 21;99(8):1285-9. doi: 10.1038/sj.bjc.6604664. Epub 2008 Sep 9. Br J Cancer. 2008. PMID: 18781171 Free PMC article.

4

Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR.

Heinemann V, Stintzing S, Kirchner T, Boeck S, Jung A. Heinemann V, et al. Among authors: kirchner t. Cancer Treat Rev. 2009 May;35(3):262-71. doi: 10.1016/j.ctrv.2008.11.005. Epub 2008 Dec 30. Cancer Treat Rev. 2009. PMID: 19117687 Review.

5

The impact of microRNAs on colorectal cancer.

Faber C, Kirchner T, Hlubek F. Faber C, et al. Among authors: kirchner t. Virchows Arch. 2009 Apr;454(4):359-67. doi: 10.1007/s00428-009-0751-9. Epub 2009 Mar 14. Virchows Arch. 2009. PMID: 19288129 Review.

6

The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.

Horst D, Reu S, Kriegl L, Engel J, Kirchner T, Jung A. Horst D, et al. Among authors: kirchner t. Cancer. 2009 May 15;115(10):2063-70. doi: 10.1002/cncr.24254. Cancer. 2009. PMID: 19298008 Free article.

7

CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.

Horst D, Kriegl L, Engel J, Jung A, Kirchner T. Horst D, et al. Among authors: kirchner t. Eur J Cancer. 2009 Jul;45(11):2034-40. doi: 10.1016/j.ejca.2009.04.004. Epub 2009 May 4. Eur J Cancer. 2009. PMID: 19403300

8

The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status.

Stintzing S, Heinemann V, Moosmann N, Hiddemann W, Jung A, Kirchner T. Stintzing S, et al. Among authors: kirchner t. Dtsch Arztebl Int. 2009 Mar;106(12):202-6. doi: 10.3238/arztebl.2009.0202. Epub 2009 Mar 20. Dtsch Arztebl Int. 2009. PMID: 19471640 Free PMC article. Review.

9

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.

Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, Jung A. Horst D, et al. Among authors: kirchner t. J Pathol. 2009 Dec;219(4):427-34. doi: 10.1002/path.2597. J Pathol. 2009. PMID: 19621338

10

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.

Horst D, Kriegl L, Engel J, Kirchner T, Jung A. Horst D, et al. Among authors: kirchner t. Cancer Invest. 2009 Oct;27(8):844-50. doi: 10.1080/07357900902744502. Cancer Invest. 2009. PMID: 19626493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters